Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Wesana Health Holdings Inc C.WESA.X

Alternate Symbol(s):  WSNAF

Wesana Health Holdings Inc. is a Canada-based company. The Company is not engaged in any business activities. The Company is looking for new business opportunities.

Recent & Breaking News (CSE:WESA.X)

Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer

GlobeNewswire January 25, 2022

Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol

GlobeNewswire January 18, 2022

Wesana Health Provides Strategic and Operational Updates

GlobeNewswire January 12, 2022

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

GlobeNewswire January 11, 2022

Canadian Securities Exchange's November 2021 Performance Includes Strong Listings Growth and New Financing Milestone

Newsfile December 15, 2021

MAPS and Wesana Health Resume Negotiations

GlobeNewswire December 14, 2021

Wesana Completes Filing of PCT Patents for Novel Drug Protocols

GlobeNewswire December 9, 2021

Wesana Health Reports Q3 2021 Financial Results

GlobeNewswire November 29, 2021

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

GlobeNewswire November 19, 2021

Wesana Health to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

PR Newswire October 11, 2021

Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF

GlobeNewswire October 1, 2021

Wesana Health Commits Funding of $1.5 Million To Support MAPS' Research Pipeline

GlobeNewswire September 14, 2021

Wesana Health Announces Closing of PsyTech Acquisition

GlobeNewswire September 9, 2021

Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board

GlobeNewswire August 31, 2021

Wesana Health: Early Warning News Release

GlobeNewswire August 24, 2021

Wesana Health Highlights Recent Appointments to Board of Directors

GlobeNewswire August 19, 2021

Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury

GlobeNewswire August 11, 2021

Wesana Health Announces Listing on OTCQB® Venture Market

GlobeNewswire August 2, 2021

Ian Burnstein Joins Wesana Health Board of Directors

GlobeNewswire July 16, 2021

Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions

GlobeNewswire July 14, 2021